Skip to main content
PLOS One logoLink to PLOS One
. 2025 Jul 8;20(7):e0327383. doi: 10.1371/journal.pone.0327383

Patient education for older adults with cancer and their caregivers: Protocol for a scoping review

Lu Lin 1,2, Janet Papadakos 3, Rouhi Fazelzad 4, Kristen Haase 5, Shabbir Alibhai 6, Fay Bennie 7, Martine Puts 8,*
Editor: Sascha Köpke9
PMCID: PMC12237015  PMID: 40627635

Abstract

Treatment decision-making for older adults is complex due to multimorbidity, polypharmacy, and age-related changes such as sensory impairment and cognitive decline. In addition, many older adults have lower health literacy, which impacts their ability to access, understand, and apply health information. Patient education plays a critical role to comprehend a new cancer diagnosis, explore treatment options, and manage care effectively. To be effective, education materials must be specifically tailored to the needs of this population. Despite growing recognition of the importance of geriatric-specific cancer education, no recent review has synthesized the literature on educational interventions or materials developed for this population. This review aims to answer the question: What is known about patient education interventions and materials developed for older adults with cancer and their caregivers and their effectiveness to improve outcomes?. We will follow the Arksey and O’Malley framework, refined by Levac et al., and report according to the PRISMA-ScR checklist. We will search Medline ALL, Embase, Emcare, Cochrane Central, PsycInfo (all via OvidSP), and Scopus (via Elsevier) for studies published from 2000 onward and complete a manual search of the references of included studies. A health sciences librarian conducted the searches. We will include peer-reviewed and relevant grey literature. Stakeholder consultation will be conducted to inform interpretation of findings and identify gaps. Eligible studies will use qualitative or quantitative designs focused on geriatric oncology patient education. Two reviewers will independently screen studies and extract data using Covidence and Excel. Data will be analyzed using descriptive statistics and narrative synthesis. The quality of peer-reviewed studies will be appraised with the Mixed Methods Appraisal Tool (2018) for descriptive purposes only. This scoping review will map existing educational interventions and materials for older adults with cancer, support clinicians in practice, and highlight gaps to inform future research and development.

Introduction

Cancer is a disease that mostly affects older adults [1]. In most countries around the world the number of older adults diagnosed with cancer will increase significantly in the next years [1]. Older adults often have comorbid conditions, polypharmacy, falls and other geriatric syndromes, that could impact cancer treatment risks and benefits [2]. However, these older adults are underrepresented in clinical research and thus there is little evidence to guide treatment decision making by the clinical team [3]. The American Society of Clinical Oncology has published geriatric oncology guidelines recommending that every older adult aged 65 years and over considered for any cancer treatment should have a geriatric assessment to guide the cancer treatment and supportive care plan [2]. Several surveys have shown knowledge gaps among the various oncology providers in terms of how to conduct a comprehensive geriatric assessment [4–8].

To reduce this knowledge gap, many geriatric oncology educational modules target providers showing them how to conduct geriatric assessments [9,10]. A previous systematic review on therapeutic education for older adults with cancer with a search conducted of papers published between 1990 and 2016 showed only 14 papers and of those only 7 targeted older adults [11]. In this review, education was part of a larger intervention that included symptom management, exercises or rehabilitation or medication adherence intervention, but none seemed to address specific geriatric oncology knowledge for older adults with cancer and the education was not used as a standalone intervention, it was combined with follow-up by health care provider support. However, this review is older, and an updated review is needed [11].

Patient education is important to enhance health literacy. The WHO defines health literacy as “representing the personal knowledge and competencies that accumulate through daily activities, social interactions and across generations. Personal knowledge and competencies are mediated by the organizational structures and availability of resources that enable people to access, understand, appraise, and use information and services in ways that promote and maintain good health and well-being for themselves and those around them.” Health literacy plays a crucial role in enhancing individuals’ ability to access, comprehend, and effectively utilize reliable health information. It empowers people to make informed personal health decisions and actively participate in collective health promotion efforts to address key health determinants [12]. Older adults may have lower levels of health literacy and ehealth literacy that can impact shared decision making as well as self-management during the treatment [13]. Low health literacy is associated with poorer health outcomes and difficulties following medication instructions and less able to make informed health decisions [14]. Patient education is essential for helping older adults and their caregivers understand a new cancer diagnosis, treatment options, and the self-management required to enhance quality of life [11,15–19]. However, due to age-related factors (such as sensory and cognitive changes), the educational needs of older cancer patients and their caregivers can differ significantly from those of younger patients [20–25]. By reviewing current evidence on educational interventions designed for older adults newly diagnosed with cancer and their caregivers, this scoping review aims to map the existing research landscape and identify effective educational content, delivery methods and the intended outcomes, to better support this population and inform future research. Therefore, our scoping review question is: What is known about patient education interventions and materials developed for older adults with cancer and their caregivers and their effectiveness to improve outcomes? We aim to map and synthesize evidence on educational interventions and materials designed specifically for older adults with cancer and their caregivers, including the type of educational content, delivery formats, and effectiveness of the education on outcomes. We will also identify gaps in current knowledge to inform future research and educational development.

Methods

This scoping review will be conducted following the framework proposed by Arksey and O’Malley [26], with subsequent refinements by Levac et al.[27]. The reporting will adhere to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) [28]. Additionally, the PRISMA-Protocol (PRISMA-P) statement was used to guide the development of this protocol [29]. The completed PRISMA-P Checklist is provided in S1 File.

Inclusion and exclusion criteria

Eligibility criteria are structured based on the PICOS (Population, Intervention, Comparison, Outcome, Study Design) framework.

Population Studies examining patient education materials for older adults (aged 65 and above) with cancer and their care partners in any clinical oncology setting (inpatient or outpatient) will be included. Studies will also be eligible if the mean participant age is over 65, if subgroup analyses for older adults are reported, or if the population is explicitly described as an older adult group.

Intervention Patient education materials (modules/websites/written materials/audiovisuals) targeting older adults with cancer and their caregivers and taking into account physical, psychological and social changes with aging and how that impacts cancer treatment risk and benefits, outcomes and treatment delivery. Types of Patient Educational interventions can include [14–18]:

  • Therapeutic patient education (defined as education aimed at enabling the patient and their relatives to cope with the disease in partnership with health professionals [11])

  • Psychosocial or behavioral education

  • Counseling with an educational component related to cancer management

  • Education delivered through various formats, including individual sessions, group classes, or digital/telehealth platforms.

Comparison: it can be any/no comparator.

Outcomes: Any relevant outcome [6,19,20], such as:

  • User data on the tool

  • Knowledge improvement and retention

  • Psychological outcomes (e.g., anxiety, depression, empowerment)

  • Health-related quality of life

  • Shared decision-making, decisional regrets

  • Treatment adherence

  • Caregiver satisfaction, burden, or stress.

Study design: All study designs will be considered eligible. Additionally, studies focusing solely on caregivers of older adults with cancer will also be included.

Exclusion criteria

  • Conference abstracts, theses, reviews, editorials, and commentaries will be excluded. However, reviews will be examined to identify any original studies that meet the inclusion criteria. For conference abstracts, study authors will be contacted to confirm whether a full study has been published.

  • Studies published before 2000 will be excluded. Recognition of the unique needs of older adults with cancer began to emerge in the 1990s, and the past two decades have seen significant advancements in cancer treatment tailored to this population. As a result, patient education materials developed prior to 2000 are likely to be less relevant to current clinical practice.

Studies that evaluate combined interventions, where the effects of patient education cannot be isolated from other components (e.g., psychological counseling), will be excluded.

Search strategy

In collaboration with an information specialist, a comprehensive literature search was conducted from 2000 to December 2024, in Medline ALL (Medline and Medline Epub Ahead of print and In-Process & Other Non-Indexed Citations), Embase, Emcare, Cochrane Central Register of Controlled Trials, and PsycInfo all from the OvidSP platform, and Scopus from Elsevier. Controlled vocabulary terms and text words adapting the database-specific search syntax will be used where available. Where applicable, the search will be restricted to human studies, and older adults based on each database-indexed age group, and exclude books, and preprints. There will be no language restrictions. The reference lists from included studies, scoping and systematic review studies will be screened to identify additional potentially relevant studies. Please see S2 File for the preliminary Medline search.

Grey literature

To identify additional relevant geriatric oncology patient education studies not captured through database searches, we will conduct a grey literature search. This will include reviewing websites of patient support organizations, the American Society of Clinical Oncology, the European Society of Medical Oncology, and various oncology nursing societies. In addition, we will include dissertations that meet the eligibility criteria, as they may contain original and relevant data not yet published in peer-reviewed journals.

Study selection and screening

Following deduplication in EndNote, references will be imported into the Covidence software [30] for further screening. Covidence’s deduplication function will also be used. Two reviewers will independently screen titles and abstracts for eligibility using Covidence. Full texts of selected studies will then be assessed by two independent reviewers based on the eligibility criteria. Any discrepancies during abstract and full-text screening will be resolved by a third reviewer. To ensure consistency, each reviewer will initially screen 50 abstracts, followed by a team discussion to address any conflicts or ambiguities before proceeding with the remaining titles and abstracts.

Data extraction

Data from eligible studies will be extracted using a standardized Microsoft Excel spreadsheet, capturing participant demographics, details of patient education materials (e.g., aim, form, content etc., theoretical framework used), control conditions, outcomes, and study design. The data extraction form, developed by the research team, is available in S3 File. The form will be piloted by two reviewers using the first five studies, with adjustments made if necessary. If any information is missing from the publication, study authors will be contacted via email, with a follow-up reminder sent after two weeks if no response is received.

Quality assessment

The quality of included peer-reviewed studies will be assessed using the 2018 version of the Mixed Methods Appraisal Tool (MMAT) [31,32] within an Excel spreadsheet, conducted alongside data extraction to provide an overview of methodological quality for descriptive purposes only. Grey literature will be included for mapping but not formally appraised. Two independent reviewers will perform the assessment, with any discrepancies resolved by a third reviewer. Studies will not be excluded based on quality assessment; rather, this process will provide an overview of the quality of the available evidence.

Summarizing and reporting results

Results will be reported following PRISMA-ScR [28], and a PRISMA flow diagram will illustrate the review process. The quality assessment findings will be summarized in a table. Data will be analyzed and reported through a combination of descriptive numerical summaries and narrative analysis. A descriptive summary will highlight the different geriatric oncology education interventions and materials developed and tested, along with the associated outcomes, including the type of educational content, delivery formats, and effectiveness of the education on outcomes. Additionally, an outcome mapping table will categorize the primary outcome types related to patient education interventions across the included studies.

Consultation

A consultation will be conducted with patients, caregivers, and clinicians involved in geriatric oncology, consistent with the optional sixth step of the scoping review methodology as proposed by Arksey and O’Malley [26] and further developed by Levac et al. [27]. This step is intended to enhance the relevance and applicability of the review findings, rather than to contribute to data collection or the narrative synthesis. Participants will be presented with a summary of the preliminary results of the review and invited to provide feedback on the comprehensiveness, clarity, and practical implications of the findings. Their input will help validate the results, highlight knowledge gaps not captured in the literature, and will inform recommendations for future research and development of patient education resources. The consultation will be conducted via Zoom and is not part of the formal data analysis. The feedback will be summarized anonymously.

Ethics statement

No personal or identifying data will be collected during this scoping review. As such, research ethics board (REB) approval is not required.

Timeline

The literature search was conducted on January 27 2025. The first draft is expected to be completed by September 2025, with the final version prepared for journal submission by December 2025.

Discussion

This scoping review is intended to summarize the state of patient education interventions and materials developed for older adults with cancer and their caregivers, including educational content, delivery methods and outcomes, and to identify knowledge gaps. These findings will be useful for informing future educational interventions and development of age-appropriate education materials for this population. The number of older adults is increasing everywhere around the world, and due to age-related changes, the older adult population has unique information needs. In addition, treatment risks and benefits may be different for older adults with cancer compared to younger patient with cancer due to multimorbidity, polypharmacy, age-related decline in physiological reserve which all impact the treatment risks and in the context of declining life expectancy, benefits from treatments. In addition, many older adults with cancer rely on a support person to help them with cancer-treatment decision-making and during the treatments.

The scoping review will explore and summarize information from previously published literature. It will not involve patients or the collection of primary research, therefore ethics approval is not required. Normally as part of the Arksey and O’Malley scoping review framework, a consultation with stakeholders is recommended [26] and this is planned for this review.

Dissemination of the scoping review results to the broad scientific community will take place through the publication of a manuscript and presentation of results at scientific and clinical conferences.

A strength of our scoping review is a comprehensive search approach including multiple databases, multiple languages and inclusion of all types of studies. A limitation is that some of the interventions that we will identify may be older and less relevant to the current clinical setting but f so we can learn from the previous studies what the next steps for geriatric oncology education should be.

Conclusion

The results of the scoping review will provide a summary of the literature regarding geriatric oncology patient education interventions which can be used by healthcare providers with older adults with cancer.

Supporting information

S1 File. PRISMA-P checklist.docx.

(DOCX)

pone.0327383.s001.docx (23.1KB, docx)
S2 File. Preliminary Medline search.

(DOCX)

pone.0327383.s002.docx (47.5KB, docx)
S3 File. Data extraction form.

(DOCX)

pone.0327383.s003.docx (16.1KB, docx)

Data Availability

No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Pilleron S, Alqurini N, Ferlay J, Haase KR, Hannan M, Janssen-Heijnen M, et al. International trends in cancer incidence in middle-aged and older adults in 44 countries. J Geriatr Oncol. 2022;13(3):346–55. doi: 10.1016/j.jgo.2021.11.011 [DOI] [PubMed] [Google Scholar]
  • 2.Dale W, Klepin HD, Williams GR, Alibhai SMH, Bergerot C, Brintzenhofeszoc K. Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update. J Clin Oncol. 2023. doi: 10.1200/JCO.23.00933 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Sedrak MS, Freedman RA, Cohen HJ, Muss HB, Jatoi A, Klepin HD, et al. Older adult participation in cancer clinical trials: A systematic review of barriers and interventions. CA Cancer J Clin. 2021;71(1):78–92. doi: 10.3322/caac.21638 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Leifer R, Bristow B, Puts M, Alibhai S, Cao X, Millar B-A, et al. National Survey Among Radiation Oncology Residents Related to Their Needs in Geriatric Oncology. J Cancer Educ. 2019;34(1):9–13. doi: 10.1007/s13187-017-1244-1 [DOI] [PubMed] [Google Scholar]
  • 5.Maggiore RJ, Callahan KE, Tooze JA, Parker IR, Hsu T, Klepin HD. Geriatrics fellowship training and the role of geriatricians in older adult cancer care: A survey of geriatrics fellowship directors. Gerontol Geriatr Educ. 2018;39(2):170–82. doi: 10.1080/02701960.2016.1247070 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Puts M, Szumacher E, Dawe D, Fitch M, Jones J, Fülöp T, et al. Never too old to learn new tricks: Surveying Canadian healthcare professionals about learning needs in caring for older adults with cancer. J Geriatr Oncol. 2020. [DOI] [PubMed] [Google Scholar]
  • 7.Puts M, Oldenmenger WH, Haase KR, Sattar S, Strohschein FJ, Stolz Baskett P. Optimizing care for older adults with cancer: International Society of Geriatric Oncology Nursing and Allied Health Interest Group and European Oncology Nursing Society survey results from nurses regarding challenges and opportunities caring for older adults with cancer. J Geriatr Oncol. 2021. [DOI] [PubMed] [Google Scholar]
  • 8.Dale W, Williams GR, A RM, Soto-Perez-de-Celis E, Maggiore RJ, Merrill JK, et al. How is geriatric assessment used in clinical practice for older adults with cancer? A survey of cancer providers by the American Society of Clinical Oncology. JCO Oncol Pract. 2020. doi: 10.1200/OP.2000442 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Nicolas C, Balardy L, Antoine V, Albarède J, Azria D, Cristol L, et al. Spreading geriatric oncology culture through professional caregivers: Results of a French massive open online course (MOOC). J Geriatr Oncol. 2022;13(1):94–9. doi: 10.1016/j.jgo.2021.08.002 [DOI] [PubMed] [Google Scholar]
  • 10.Antoine V, Nicolas C, Albarède J, Azria D, Cristol L, Jeandel C, et al. Development and assessment of a MOOC about delirium in geriatric oncology. Bull Cancer. 2021;108(12):1101–11. doi: 10.1016/j.bulcan.2021.05.014 [DOI] [PubMed] [Google Scholar]
  • 11.Champarnaud M, Villars H, Girard P, Brechemier D, Balardy L, Nourhashémi F. Effectiveness of Therapeutic Patient Education Interventions for Older Adults with Cancer: A Systematic Review. J Nutr Health Aging. 2020;24(7):772–82. doi: 10.1007/s12603-020-1395-3 [DOI] [PubMed] [Google Scholar]
  • 12.Health promotion glossary of terms. Geneva: World Health Organization. 2021. [Google Scholar]
  • 13.Papadakos JK, Hasan SM, Barnsley J, Berta W, Fazelzad R, Papadakos CJ, et al. Health literacy and cancer self-management behaviors: A scoping review. Cancer. 2018;124(21):4202–10. doi: 10.1002/cncr.31733 [DOI] [PubMed] [Google Scholar]
  • 14.Papadakos J, Barnsley J, Berta W, Rowlands G, Samoil D, Howell D. The association of self-efficacy and health literacy to chemotherapy self-management behaviors and health service utilization. Support Care Cancer. 2022;30(1):603–13. doi: 10.1007/s00520-021-06466-5 [DOI] [PubMed] [Google Scholar]
  • 15.Jansen J v WJ, van Dulmen S, Heeren T, Bensing J. Patient education about treatment in cancer care: an overview of the literature on older patients’ needs. Cancer Nursing. 2007. [DOI] [PubMed] [Google Scholar]
  • 16.Harris KA. The informational needs of patients with cancer and their families. Cancer Pract. 1998;6(1):39–46. doi: 10.1046/j.1523-5394.1998.1998006039.x [DOI] [PubMed] [Google Scholar]
  • 17.Hamaker ME, van Walree IC, Seghers PALN, van den Bos F, Soubeyran P, O’Hanlon S, et al. Information needs of older patients newly diagnosed with cancer. J Geriatr Oncol. 2022;13(3):265–72. doi: 10.1016/j.jgo.2021.09.011 [DOI] [PubMed] [Google Scholar]
  • 18.Hekman DJ, Rodakowski J, Brick RS, Cadmus-Bertram L, Fields B. Exploration of patient and caregiver cancer education using electronic health records. J Geriatr Oncol. 2022;13(1):108–10. doi: 10.1016/j.jgo.2021.06.008 [DOI] [PubMed] [Google Scholar]
  • 19.Scotté F, Bossi P, Carola E, Cudennec T, Dielenseger P, Gomes F, et al. Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide. Ann Oncol. 2018;29(8):1718–26. doi: 10.1093/annonc/mdy228 [DOI] [PubMed] [Google Scholar]
  • 20.van Weert JCM, Bolle S, van Dulmen S, Jansen J. Older cancer patients’ information and communication needs: what they want is what they get?. Patient Educ Couns. 2013;92(3):388–97. doi: 10.1016/j.pec.2013.03.011 [DOI] [PubMed] [Google Scholar]
  • 21.Posma ER, van Weert JCM, Jansen J, Bensing JM. Older cancer patients’ information and support needs surrounding treatment: An evaluation through the eyes of patients, relatives and professionals. BMC Nurs. 2009;8:1. doi: 10.1186/1472-6955-8-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Kadambi S, Loh KP, Dunne R, Magnuson A, Maggiore R, Zittel J, et al. Older adults with cancer and their caregivers - current landscape and future directions for clinical care. Nat Rev Clin Oncol. 2020;17(12):742–55. doi: 10.1038/s41571-020-0421-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Given B, Given CW. Older adults and cancer treatment. Cancer. 2008;113(12 Suppl):3505–11. doi: 10.1002/cncr.23939 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Chouliara Z, Kearney N, Stott D, Molassiotis A, Miller M. Perceptions of older people with cancer of information, decision making and treatment: a systematic review of selected literature. Ann Oncol. 2004;15(11):1596–602. doi: 10.1093/annonc/mdh423 [DOI] [PubMed] [Google Scholar]
  • 25.Seghers PALN, Rostoft S, O’Hanlon S, O’Sullivan B, Portielje JEA, Wildiers H, et al. Challenges of caring for older patients with multimorbidity including cancer. J Geriatr Oncol. 2023;14(7):101588. doi: 10.1016/j.jgo.2023.101588 [DOI] [PubMed] [Google Scholar]
  • 26.Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol 2005;8(1):19–32. [Google Scholar]
  • 27.Levac D, Colquhoun H, O’Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010;5:69. doi: 10.1186/1748-5908-5-69 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169(7):467–73. [DOI] [PubMed] [Google Scholar]
  • 29.Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. doi: 10.1186/2046-4053-4-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Covidence systematic review software. Melbourne, Australia: Veritas Health Innovation. www.covidence.org [Google Scholar]
  • 31.Hong QN, Gonzalez-Reyes A, Pluye P. Improving the usefulness of a tool for appraising the quality of qualitative, quantitative and mixed methods studies, the Mixed Methods Appraisal Tool (MMAT). J Eval Clin Pract. 2018;24(3):459–67. doi: 10.1111/jep.12884 [DOI] [PubMed] [Google Scholar]
  • 32.Hong QN, Pluye P, Fàbregues S, Bartlett G, Boardman F, Cargo M, et al. Improving the content validity of the mixed methods appraisal tool: a modified e-Delphi study. J Clin Epidemiol. 2019;111:49–59.e1. [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Sascha Köpke

PONE-D-25-04797Patient Education for Older Adults with Cancer and Their Caregivers: Protocol for a Scoping ReviewPLOS ONE

Dear Dr. Puts,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

I decided to make a decision after one review as the reviewer has highlighted the main aspects for revision of the principally suitable review protocol. Please revise the manuscript considering the reviewer’s suggestions.

In addition to the reviewer's comments some clarifications are needed: (1) I do not see why a “quality assessment” is planned as this is not recommended for scoping reviews. Also, as pointed out by the reviewer, this might not be the most suitable tool. (2) The reviewer (although erroneously referring to 5 years) is correct in questioning the reason for limiting the search to papers published since 2000. Although, I think this limitation is feasible, the reason should rather be the quality of the materials than the foundation of the society. (3) As stated by the reviewer, the abstract fails to mention the search for grey literature and the planned consultation. I find it surprising that e.g. dissertations are excluded while information from websites will be included. Please explain. The purpose of the consultation is not clear. Is this part of the search for “grey literature” or of the narrative summary or will the participants be presented the results of the review and asked to draw conclusions and give recommendations from the results? This should either be deleted or reported in more detail. (4) Also the “narrative summary” should be reported in more detail. What do you anticipate that will be reported, e.g. types  of materials, content of materials etc.? Are you planning to use any specific methods (cf. the Cochrane handbook chapter on narrative syntheses). (5) Although Prisma-ScR is given as reporting guideline, the appendix presents Prisma-P. Please clarify. (6) In line 103, please exchange pe by patient education.

Please submit your revised manuscript by Jun 12 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Sascha Köpke

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Partly

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Partly

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: No

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear authors,

thank you for introducing this interesting manuscript on “Patient Education for Older Adults with Cancer and Their Caregivers: Protocol for a Scoping Review”. The topic is contemporary and important, however the manuscript still requires revisions.

Here are my recommendations for revisions

The purpose of the review needs to be clarified. The introduction chapter is written so that there is some unclarity is the review aiming to fill in gaps of health care providers knowledge or is it providing summary on what constitutes quality patient education tailored to needs of older adults with cancer based on previous literature. Please, review critically the introduction chapter for clarity. In the discussion or conclusion, I would expect you to come back on the knowledge gaps, if this review is aiming also to fill in those (how will the results be used).

Abstract refers to scoping review that combines studies with different methodologies, however, in the manuscript method section, grey literature and consultation of patients, caregivers and clinicians is introduced. Please revise abstract accordingly.

The research questions is broad and varies in the manuscript. What is known about patient educational materials that have been developed for older adults with cancer, aims to identify and synthesize evidence on patient education (educational content, preferred delivery methods, and intended outcomes). This raises question on focus such as is the interest also on effectiveness of interventions and instruments used to assess the effect or impact etc. In the abstract and beginning of discussion, there is mention that focus is on materials, however, later in the manuscript it is also mentioned that review has focus on interventions (is this the delivery methods?). Which is it? Please review purpose and aims to ensure logic and clarity.

The reasons given for 5 years limit is explained, however, I am not sure that establishment year of a society is a reason, and moreover, has there been major development on patient education of the population just in 5 years, as mentioned there has been interest since of 1990’, and patient education from general view (such as empowering patient education) has been research interest for longer time than just 5 years.

Although actual research data is not collected on the Zoom calls with patients, caregivers and clinicians indicating that ethical review process is not needed, there is ethical matters to discuss (such as data privacy etc.).

Quality assessment. If you intent to use the MMAT which is for mixed methods studies. how suitable it is for the grey literature?

I hope you will work on the manuscript further and resubmit it again.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

PLoS One. 2025 Jul 8;20(7):e0327383. doi: 10.1371/journal.pone.0327383.r002

Author response to Decision Letter 1


12 May 2025

Dear Dr. Köpke,

We would like to thank you and the reviewer for the time spent on the manuscript, we have revised the manuscript according to the suggestions. Below we have provided a point-by-point response to each comment raised.

With kind regards,

Martine Puts on behalf of all authors

Editor’s Comments:

I do not see why a “quality assessment” is planned as this is not recommended for scoping reviews. Also, as pointed out by the reviewer, this might not be the most suitable tool.

� We acknowledge that quality assessment is not a required element of scoping reviews but optional. However, we have included it to provide an overview of the methodological rigor of included studies to be able to formulate clearer recommendations for future research based on the quality of the evidence. We have clarified this rationale in the revised protocol in the abstract and in the Methods section under “Quality assessment”. Regarding tool suitability, we have reconsidered the use of the MMAT and now indicate that it will be used solely for descriptive purposes, without influencing inclusion decisions. Eligible grey literature will be included but will not be formally appraised using the MMAT or any other tool.

� Revised text abstract on page 3:

The quality of peer-reviewed studies will be appraised with the Mixed Methods Appraisal Tool (2018) for descriptive purposes only.

� Revised text in methods section on page 12:

The quality of included peer-reviewed studies will be assessed using the 2018 version of the Mixed Methods Appraisal Tool (MMAT) (31, 32) within an Excel spreadsheet, conducted alongside data extraction to provide an overview of methodological quality for descriptive purposes only.

The reviewer (although erroneously referring to 5 years) is correct in questioning the reason for limiting the search to papers published since 2000. Although, I think this limitation is feasible, the reason should rather be the quality of the materials than the foundation of society.

� Thank you for this insightful comment. We have removed the reference to the establishment of the International Society of Geriatric Oncology in 2000 as justification for the publication time restriction. Instead, we now emphasize that the decision to include studies from 2000 onward is based on the increasing attention to geriatric-specific patient education and the improved quality and relevance of materials developed in the past two decades.

� Revised text on page 9:

Recognition of the unique needs of older adults with cancer began to emerge in the 1990s, and the past two decades have seen significant advancements in cancer treatment tailored to this population. As a result, patient education materials developed prior to 2000 are likely to be less relevant to current clinical practice.

As stated by the reviewer, the abstract fails to mention the search for grey literature and the planned consultation.

� We have revised the abstract to include both the grey literature search and the planned consultation.

� New text on page 4:

We will include peer-reviewed and relevant grey literature. Stakeholder consultation will be conducted to inform interpretation of findings and identify gaps.

I find it surprising that e.g. dissertations are excluded while information from websites will be included. Please explain.

� Initially, we excluded dissertations as we assumed many would already be published in peer-reviewed journals. However, we acknowledge the value that dissertations can add, particularly in capturing emerging or underreported work. In response to your suggestion, we have revised our inclusion criteria to allow dissertations that meet our eligibility standards.

� Revised text on page 4 (Abstract):

We will include peer-reviewed and relevant grey literature. Stakeholder consultation will be conducted to inform interpretation of findings and identify gaps.

� Revised text in methods on page 10:

In addition, we will include dissertations that meet the eligibility criteria, as they may contain original and relevant data not yet published in peer-reviewed journals.

The purpose of the consultation is not clear. Is this part of the search for “grey literature” or of the narrative summary or will the participants be presented the results of the review and asked to draw conclusions and give recommendations from the results? This should either be deleted or reported in more detail.

� We have revised the manuscript to clarify the purpose of the consultation. The consultation is an optional sixth step of the scoping review methodology, as recommended by Arksey and O’Malley and expanded by Levac et al. Its purpose is to present the preliminary findings of the review to patients, caregivers, and clinicians in geriatric oncology, and to gather their feedback on the relevance, completeness, and practical implications of the results. This feedback will help identify knowledge gaps and inform directions for future research and educational development.

� Revised text on page 13:

A consultation will be conducted with patients, caregivers, and clinicians involved in geriatric oncology, consistent with the optional sixth step of the scoping review methodology as proposed by Arksey and O’Malley and further developed by Levac et al. This step is intended to enhance the relevance and applicability of the review findings, rather than to contribute to data collection or the narrative synthesis. Participants will be presented with a summary of the preliminary results of the review and invited to provide feedback on the comprehensiveness, clarity, and practical implications of the findings. Their input will help validate the results, highlight knowledge gaps not captured in the literature, and inform recommendations for future research and development of patient education resources. The consultation will be conducted via Zoom and is not part of formal data analysis. No personal or identifying data will be collected, and participation will be voluntary. As such, research ethics board (REB) approval is not required, but ethical practices, including informed consent, data privacy, and anonymization of feedback, will be followed.

Also the “narrative summary” should be reported in more detail. What do you anticipate that will be reported, e.g. types of materials, content of materials etc.? Are you planning to use any specific methods (cf. the Cochrane handbook chapter on narrative syntheses).

� We have expanded the relevant section to clarify that the narrative summary will describe the type of educational content, delivery formats, and effectiveness of the education on outcomes. Although we do not plan to conduct a formal narrative synthesis as outlined in the Cochrane Handbook, we will apply a thematic grouping approach to organize and report the findings, highlighting trends, variations, and gaps across the included studies.

� Revised text on page 12:

Data will be analyzed and reported through a combination of descriptive numerical summaries and narrative analysis. A descriptive summary will highlight the different geriatric oncology education interventions and materials developed and tested, along with the associated outcomes, including the type of educational content, delivery formats, and effectiveness of the education on outcomes.

Although Prisma-ScR is given as reporting guideline, the appendix presents Prisma-P. Please clarify.

� Thank you for your observation. As this manuscript is only a protocol for a scoping review that has not yet been completed, we included the PRISMA-P checklist in the Appendix to guide protocol development. Once the review is completed, the results will be reported in accordance with the PRISMA-ScR guideline, as stated in the Methods section.

In line 103, please exchange pe by patient education.

� We have corrected the phrase in line 103 from “pe” to “patient education”.

Reviewer #1:

Dear authors,

thank you for introducing this interesting manuscript on “Patient Education for Older Adults with Cancer and Their Caregivers: Protocol for a Scoping Review”. The topic is contemporary and important, however the manuscript still requires revisions.

Here are my recommendations for revisions

� The purpose of the review needs to be clarified. The introduction chapter is written so that there is some unclarity is the review aiming to fill in gaps of health care providers knowledge or is it providing summary on what constitutes quality patient education tailored to needs of older adults with cancer based on previous literature. Please, review critically the introduction chapter for clarity. In the discussion or conclusion, I would expect you to come back on the knowledge gaps, if this review is aiming also to fill in those (how will the results be used).

� We have revised the Introduction and Discussion sections to clarify that the primary aim of this scoping review is to map the characteristics of patient education interventions and materials developed for older adults with cancer and their caregivers, including the type of educational content, delivery formats, and effectiveness of the education on outcomes. While we are not directly evaluating healthcare provider knowledge gaps, we seek to identify gaps in the existing literature to inform future research and development of tailored educational interventions.

� Revised text on page 7 (Introduction)

We aim to map and synthesize evidence on educational interventions and materials designed specifically for older adults with cancer and their caregivers, including the type of educational content, delivery formats, and effectiveness of the education on outcomes. We will also identify gaps in current knowledge to inform future research and educational development.

� Revised text on page 13-14 (Discussion)

This scoping review is intended to summarize the state of patient education interventions and materials developed for older adults with cancer and their caregivers, including educational content, delivery methods and outcomes, and to identify knowledge gaps. These findings will be useful for informing future educational interventions and development of age-appropriate education materials for this population.

Abstract refers to scoping review that combines studies with different methodologies, however, in the manuscript method section, grey literature and consultation of patients, caregivers and clinicians is introduced. Please revise abstract accordingly.

� We have revised the abstract to include both the grey literature search and the planned consultation.

The research questions is broad and varies in the manuscript. What is known about patient educational materials that have been developed for older adults with cancer, aims to identify and synthesize evidence on patient education (educational content, preferred delivery methods, and effectiveness of the education on outcomes). This raises question on focus such as is the interest also on effectiveness of interventions and instruments used to assess the effect or impact etc. In the abstract and beginning of discussion, there is mention that focus is on materials, however, later in the manuscript it is also mentioned that review has focus on interventions (is this the delivery methods?). Which is it? Please review purpose and aims to ensure logic and clarity.

� We appreciate this observation. The research question and objectives have now been revised for consistency across the Abstract, Introduction, and Methods. The research question is stated as: What is known about patient education interventions and materials developed for older adults with cancer and their caregivers and their effectiveness to improve outcomes? We aim to identify and synthesize published evidence on the content, delivery methods, and outcomes of patient education interventions and materials designed specifically for older adults with cancer and their caregivers. Where applicable, we will also extract information on the effectiveness of educational interventions, if such data are reported in the studies included.

The reasons given for 5 years limit is explained, however, I am not sure that establishment year of a society is a reason, and moreover, has there been major development on patient education of the population just in 5 years, as mentioned there has been interest since of 1990’, and patient education from general view (such as empowering patient education) has been research interest for longer time than just 5 years.

� We have removed the reference to the establishment of the International Society of Geriatric Oncology in 2000 as justification for the publication time restriction. Instead, we now emphasize that the decision to include studies from 2000 onward is based on the increasing attention to geriatric-specific patient education and the improved quality and relevance of materials developed in the past two decades.

� Although actual research data is not collected on the Zoom calls with patients, caregivers and clinicians indicating that ethical review process is not needed, there is ethical matters to discuss (such as data privacy etc.).

� We agree that, although formal ethics approval is not required, ethical considerations remain important. In response, we have revised the “Ethical Considerations” section to clarify that participation will be entirely voluntary and that ethical practices, including informed consent, data privacy, and anonymization of feedback, will be strictly followed to ensure transparency and respect for participants.

Quality assessment. If you intent to use the MMAT which is for mixed methods studies. how suitable it is for the grey literature?

� We agree that the MMAT is not appropriate for grey literature. We have clarified in the Quality Assessment section that only peer-reviewed studies will undergo quality appraisal using MMAT. Eligible grey literature will be included and mapped but will not be formally appraised using the MMAT or any other tool.

I hope you will work on the manuscript further and resubmit it again.

� We sincerely appreciate your time and valuable insights. In response, we have critically revised the manuscript to improve clarity, consistency, and methodological rigor.

Attachment

Submitted filename: Responses to Reviewer Comments 20250509.docx

pone.0327383.s004.docx (29.4KB, docx)

Decision Letter 1

Sascha Köpke

Patient Education for Older Adults with Cancer and Their Caregivers: Protocol for a Scoping Review

PONE-D-25-04797R1

Dear Dr. Puts,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Sascha Köpke

Academic Editor

PLOS ONE

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for resubmitting the manuscript on “Patient Education for Older Adults with Cancer and Their Caregivers: Protocol for a Scoping Review”. I am satisfied with the revisions completed.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: Yes:  Virpi Sulosaari

**********

Acceptance letter

Sascha Köpke

PONE-D-25-04797R1

PLOS ONE

Dear Dr. Puts,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Sascha Köpke

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. PRISMA-P checklist.docx.

    (DOCX)

    pone.0327383.s001.docx (23.1KB, docx)
    S2 File. Preliminary Medline search.

    (DOCX)

    pone.0327383.s002.docx (47.5KB, docx)
    S3 File. Data extraction form.

    (DOCX)

    pone.0327383.s003.docx (16.1KB, docx)
    Attachment

    Submitted filename: Responses to Reviewer Comments 20250509.docx

    pone.0327383.s004.docx (29.4KB, docx)

    Data Availability Statement

    No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES